Hepatitis C Virus' initial encounters: Mechanisms of innate immunity

Frontiers in Bioscience

Volumn 17, Issue 1, 2012, Pages 281-299

  Eksioglu, Erika Adriana ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Dendritic Cells; HCV; Innate Immunity; Interferon Response; Review; RIG I; TLR3

Indexed keywords

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 84860283422     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3927     Document Type: Article

References (173)

1. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow & H. S. Margolis: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med, 341, 556-62 (1999) (Pubitemid 29384163)
2. Anonymous: Global survillence and control of hepatitis C. J. Viral Hepat., 6, 35-47 (1999)
3. Cerny, A. & F. V. Chisari: Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology, 30, 595-601 (1999) (Pubitemid 29409400)
4. Shepard, C. W., L. Finelli & M. J. Alter: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis, 5, 558-67 (2005) (Pubitemid 41196755)
5. Davis, G. L.: Combination treatment with interferon and ribavirin for chronic hepatitis C. Clin Liver Dis, 3, 811-26 (1999)
6. Foster, G. R.: Past, present, and future hepatitis C treatments. Semin Liver Dis, 24 Suppl 2, 97-104 (2004) (Pubitemid 39180712)
7. Pawlotsky, J. M.: Hepatitis C virus resistance to antiviral therapy. Hepatology, 32, 889-96 (2000)
8. Thimme, R. & O. G. Opitz: Interleukin-10 and viral clearance: translation to viral hepatitis. Gastroenterology, 132, 2611-3 (2007) (Pubitemid 46890883)
9. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern & M. B. Oldstone: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med, 12, 1301-9 (2006) (Pubitemid 44706933)
10. Echeverria, I., A. Zabaleta, L. Silva, N. Diaz-Valdes, J. I. Riezu-Boj, J. J. Lasarte, F. Borras-Cuesta, M. P. Civeira, J. Prieto & P. Sarobe: Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). J Viral Hepat (2008)
11. Bowen, D. G. & C. M. Walker: Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 436, 946-52 (2005) (Pubitemid 41191670)
12. Brady, M. T., A. J. MacDonald, A. G. Rowan & K. H. Mills: Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol, 33, 3448-57 (2003) (Pubitemid 37541123)
13. Barnes, E., M. Salio, V. Cerundolo, J. Medlin, S. Murphy, G. Dusheiko & P. Klenerman: Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob Agents Chemother, 48, 3382-9 (2004) (Pubitemid 39129334)
14. Villacres, M. C., O. Literat, M. DeGiacomo, W. Du, T. Frederick & A. Kovacs: Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J Viral Hepat, 15, 137-44 (2008)
15. Kanto, T., M. Inoue, M. Miyazaki, I. Itose, H. Miyatake, M. Sakakibara, T. Yakushijin, A. Kaimori, C. Oki, N. Hiramatsu, A. Kasahara & N. Hayashi: Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology, 49, 58-63 (2006) (Pubitemid 41318177)
16. Longman, R. S., A. H. Talal, I. M. Jacobson, C. M. Rice & M. L. Albert: Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis, 192, 497-503 (2005) (Pubitemid 41023130)
17. Kanto, T., M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, T. Yakushijin, C. Oki, I. Itose, N. Hiramatsu, T. Takehara, A. Kasahara & N. Hayashi: Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis, 190, 1919-26 (2004) (Pubitemid 39564696)
18. Wertheimer, A. M., A. Bakke & H. R. Rosen: Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology, 40, 335-45 (2004) (Pubitemid 39062851)
19. Murakami, H., S. M. Akbar, H. Matsui, N. Horiike & M. Onji: Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol, 137, 559-65 (2004) (Pubitemid 39128083)
20. Kakumu, S., S. Ito, T. Ishikawa, Y. Mita, T. Tagaya, Y. Fukuzawa & K. Yoshioka: Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol, 15, 431-6 (2000) (Pubitemid 30262212)
21. Anthony, D. D., N. L. Yonkers, A. B. Post, R. Asaad, F. P. Heinzel, M. M. Lederman, P. V. Lehmann & H. Valdez: Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol, 172, 4907-16 (2004) (Pubitemid 38456415)
22. Tsubouchi, E., S. M. Akbar, H. Murakami, N. Horiike & M. Onji: Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol, 137, 417-23 (2004) (Pubitemid 39013090)
23. Rollier, C., J. A. Drexhage, B. E. Verstrepen, E. J. Verschoor, R. E. Bontrop, G. Koopman & J. L. Heeney: Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology, 38, 851-8 (2003) (Pubitemid 37221668)
24. Bain, C., A. Fatmi, F. Zoulim, J. P. Zarski, C. Trepo & G. Inchauspe: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology, 120, 512-24 (2001) (Pubitemid 32147649)
25. Auffermann-Gretzinger, S., E. B. Keeffe & S. Levy: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood, 97, 3171-6 (2001)
26. Kanto, T., N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, A. Ito, Y. Sasaki, A. Kasahara & M. Hori: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol, 162, 5584-91 (1999) (Pubitemid 29307172)
27. Sarobe, P., J. J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta & J. Prieto: Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol, 76, 5062-70 (2002) (Pubitemid 34441711)
28. Piccioli, D., S. Tavarini, S. Nuti, P. Colombatto, M. Brunetto, F. Bonino, P. Ciccorossi, F. Zorat, G. Pozzato, C. Comar, S. Abrignani & A. Wack: Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol, 42, 61-7 (2005) (Pubitemid 40038901)
29. Longman, R. S., A. H. Talal, I. M. Jacobson, M. L. Albert & C. M. Rice: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood, 103, 1026-9 (2004) (Pubitemid 38129566)
30. Dolganiuc, A., K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics, Jr., P. Mandrekar, M. Zapp & G. Szabo: Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol, 170, 5615-24 (2003) (Pubitemid 36617852)
31. Saito, K., M. Ait-Goughoulte, S. M. Truscott, K. Meyer, A. Blazevic, G. Abate, R. B. Ray, D. F. Hoft & R. Ray: Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol, 82, 3320-8 (2008) (Pubitemid 351429910)
32. Evans, M. J., T. von Hahn, D. M. Tscherne, A. J. Syder, M. Panis, B. Wolk, T. Hatziioannou, J. A. McKeating, P. D. Bieniasz & C. M. Rice: Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, 446, 801-5 (2007) (Pubitemid 46582027)
33. Caparros, E., P. Munoz, E. Sierra-Filardi, D. Serrano-Gomez, A. Puig-Kroger, J. L. Rodriguez-Fernandez, M. Mellado, J. Sancho, M. Zubiaur & A. L. Corbi: DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood, 107, 3950-8 (2006) (Pubitemid 43726801)
34. Barth, H., E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, M. Lambotin & T. F. Baumert: Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol, 82, 3466-79 (2008) (Pubitemid 351429922)
35. Barth, H., A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, E. Depla, T. J. Liang, H. E. Blum & T. F. Baumert: Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood, 105, 3605-14 (2005) (Pubitemid 40628207)
36. Chang, S., K. Kodys & G. Szabo: Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology, 51, 35-42
37. Lai, W. K., P. J. Sun, J. Zhang, A. Jennings, P. F. Lalor, S. Hubscher, J. A. McKeating & D. H. Adams: Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol, 169, 200-8 (2006)
38. Kato, T., T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami & T. Wakita: Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology, 125, 1808-17 (2003) (Pubitemid 37500445)
39. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager & T. J. Liang: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med, 11, 791-6 (2005) (Pubitemid 41021213)
40. Miyazaki, M., T. Kanto, M. Inoue, I. Itose, H. Miyatake, M. Sakakibara, T. Yakushijin, N. Kakita, N. Hiramatsu, T. Takehara, A. Kasahara & N. Hayashi: Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol, 80, 980-8 (2008) (Pubitemid 351657008)
41. Tang, T. J., D. Vukosavljevic, H. L. Janssen, R. S. Binda, S. Mancham, H. W. Tilanus, J. N. Ijzermans, H. Drexhage & J. Kwekkeboom: Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma. Hum Pathol, 37, 332-8 (2006) (Pubitemid 43277521)
42. Shiina, M., K. Kobayashi, T. Kobayashi, Y. Kondo, Y. Ueno & T. Shimosegawa: Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients. J Gastroenterol, 41, 758-64 (2006) (Pubitemid 44446129)
43. Torresi, J., M. Bharadwaj, D. C. Jackson & E. J. Gowans: Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy. Curr Drug Targets, 5, 41-56 (2004) (Pubitemid 38081741)
44. Pachiadakis, I., G. Pollara, B. M. Chain & N. V. Naoumov: Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis, 5, 296-304 (2005) (Pubitemid 40602249)
45. Shiina, M. & B. Rehermann: Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology, 47, 385-95 (2008) (Pubitemid 351280706)
46. Eksioglu, E. A., J. R. Bess, H. Zhu, Y. Xu, H. J. Dong, J. Elyar, D. R. Nelson & C. Liu: Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat (2009)
47. Sarobe, P., J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, I. Melero, F. Borras-Cuesta & J. Prieto: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol, 77, 10862-71 (2003) (Pubitemid 37204279)
48. Szabo, G. & A. Dolganiuc: Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology, 210, 237-47 (2005) (Pubitemid 41025165)
49. Yu, H., H. Huang, J. Xiang, L. A. Babiuk & S. van Drunen Littel-van den Hurk: Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. J Gen Virol, 87, 1-10 (2006) (Pubitemid 43056938)
50. Encke, J., J. Findeklee, J. Geib, E. Pfaff & W. Stremmel: Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clin Exp Immunol, 142, 362-9 (2005) (Pubitemid 41565254)
51. Wang, Q. C., Z. H. Feng, Y. X. Zhou & Q. H. Nie: Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor. World J Gastroenterol, 11, 557-60 (2005)
52. Racanelli, V., S. E. Behrens, J. Aliberti & B. Rehermann: Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. Immunity, 20, 47-58 (2004) (Pubitemid 38134293)
53. Li, W., J. Li, D. L. Tyrrell & B. Agrawal: Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities. J Gen Virol, 87, 61-72 (2006) (Pubitemid 43056944)
54. Heiser, A., D. Coleman, J. Dannull, D. Yancey, M. A. Maurice, C. D. Lallas, P. Dahm, D. Niedzwiecki, E. Gilboa & J. Vieweg: Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest, 109, 409-17 (2002) (Pubitemid 34141815)
55. Thumann, C., E. Schvoerer, J. D. Abraham, A. Bohbot, F. Stoll-Keller, A. M. Aubertin & M. P. Kieny: Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroenterol Clin Biol, 32, 59-68 (2008) (Pubitemid 351635685)
56. Colonna, M., B. Pulendran & A. Iwasaki: Dendritic cells at the host-pathogen interface. Nat Immunol, 7, 117-20 (2006) (Pubitemid 43135873)
57. Assier, E., V. Marin-Esteban, A. Haziot, E. Maggi, D. Charron & N. Mooney: TLR7/8 agonists impair monocytederived dendritic cell differentiation and maturation. J Leukoc Biol, 81, 221-8 (2007) (Pubitemid 46021272)
58. Liu, Y. J.: IPC: professional type 1 interferonproducing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol, 23, 275-306 (2005)
59. Izaguirre, A., B. J. Barnes, S. Amrute, W. S. Yeow, N. Megjugorac, J. Dai, D. Feng, E. Chung, P. M. Pitha & P. Fitzgerald-Bocarsly: Comparative analysis of IRF and IFNalpha expression in human plasmacytoid and monocytederived dendritic cells. J Leukoc Biol, 74, 1125-38 (2003) (Pubitemid 38040335)
60. Miyatake, H., T. Kanto, M. Inoue, M. Sakakibara, A. Kaimori, T. Yakushijin, I. Itose, M. Miyazaki, N. Kuzushita, N. Hiramatsu, T. Takehara, A. Kasahara & N. Hayashi: Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. J Viral Hepat, 14, 404-12 (2007) (Pubitemid 46744052)
61. Szabo, G. & A. Dolganiuc: Hepatitis C and innate immunity: recent advances. Clin Liver Dis, 12, 675-92, x (2008) (Pubitemid 351952475)
62. Taylor, M. W., T. Tsukahara, L. Brodsky, J. Schaley, C. Sanda, M. J. Stephens, J. N. McClintick, H. J. Edenberg, L. Li, J. E. Tavis, C. Howell & S. H. Belle: Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol, 81, 3391-401 (2007) (Pubitemid 46456648)
63. Yonkers, N. L., B. Rodriguez, K. A. Milkovich, R. Asaad, M. M. Lederman, P. S. Heeger & D. D. Anthony: TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J Immunol, 178, 4436-44 (2007) (Pubitemid 46492395)
64. Dolganiuc, A., S. Chang, K. Kodys, P. Mandrekar, G. Bakis, M. Cormier & G. Szabo: Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol, 177, 6758-68 (2006) (Pubitemid 44715040)
65. Nattermann, J., H. Zimmermann, A. Iwan, M. von Lilienfeld-Toal, L. Leifeld, H. D. Nischalke, B. Langhans, T. Sauerbruch & U. Spengler: Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology, 44, 945-54 (2006) (Pubitemid 46489559)
66. Gary-Gouy, H., P. Lebon & A. H. Dalloul: Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res, 22, 653-9 (2002) (Pubitemid 35034523)
67. Piazzolla, G., C. Tortorella, O. Schiraldi & S. Antonaci: Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol, 20, 54-61 (2000) (Pubitemid 30210107)
68. Jia, H. Y., J. Du, S. H. Zhu, Y. J. Ma, H. Y. Chen, B. S. Yang & H. F. Cai: The roles of serum IL-18, IL-10, TNFalpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int, 1, 378-82 (2002) (Pubitemid 36748769)
69. Ebihara, T., M. Shingai, M. Matsumoto, T. Wakita & T. Seya: Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology, 48, 48-58 (2008) (Pubitemid 351975530)
70. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, T. Suzuki, T. Miyagi & N. Hayashi: Autocrine/paracrine IL-15 that is required for type I IFNmediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol, 171, 5423-9 (2003) (Pubitemid 37432829)
71. Mozer-Lisewska, I., G. Dworacki, E. Kaczmarek, W. Sluzewski, M. Kaczmarek, A. Wozniak & J. Zeromski: Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-the role of dendritic cells. Scand J Immunol, 63, 311-9 (2006)
72. Foster, G. R. & N. B. Finter: Are all type I human interferons equivalent? J Viral Hepat, 5, 143-52 (1998) (Pubitemid 28374722)
73. Levy, S., S. C. Todd & H. T. Maecker: CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol, 16, 89-109 (1998) (Pubitemid 28183360)
74. Crotta, S., A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Brunetto, F. Bonino, S. Abrignani & N. M. Valiante: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med, 195, 35-41 (2002) (Pubitemid 34074494)
75. Naka, K., H. Dansako, N. Kobayashi, M. Ikeda & N. Kato: Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology, 346, 348-62 (2006) (Pubitemid 43357878)
76. Broering, R., J. Wu, Z. Meng, P. Hilgard, M. Lu, M. Trippler, A. Szczeponek, G. Gerken & J. F. Schlaak: Tolllike receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol, 48, 914-22 (2008)
77. Gale, M., Jr. & E. M. Foy: Evasion of intracellular host defence by hepatitis C virus. Nature, 436, 939-45 (2005) (Pubitemid 41191669)
78. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman & R. D. Schreiber: How cells respond to interferons. Annu Rev Biochem, 67, 227-64 (1998) (Pubitemid 28411130)
79. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr. & S. M. Lemon: Immune evasion by hepatitis C virus NS3/4A proteasemediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A, 102, 2992-7 (2005) (Pubitemid 40299904)
80. Kanda, T., R. Steele, R. Ray & R. B. Ray: Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol, 81, 12375-81 (2007) (Pubitemid 350085851)
81. Thomas, A., C. Laxton, J. Rodman, N. Myangar, N. Horscroft & T. Parkinson: Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother, 51, 2969-78 (2007) (Pubitemid 47206238)
82. Sumpter, R., Jr., Y. M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S. M. Lemon & M. Gale, Jr.: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol, 79, 2689-99 (2005) (Pubitemid 40270547)
83. Binder, M., G. Kochs, R. Bartenschlager & V. Lohmann: Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology, 46, 1365-74 (2007) (Pubitemid 350155518)
84. Zhu, H., H. Zhao, C. D. Collins, S. E. Eckenrode, Q. Run, R. A. McIndoe, J. M. Crawford, D. R. Nelson, J. X. She & C. Liu: Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology, 37, 1180-8 (2003) (Pubitemid 36538696)
85. Saito, T., R. Hirai, Y. M. Loo, D. Owen, C. L. Johnson, S. C. Sinha, S. Akira, T. Fujita & M. Gale, Jr.: Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A, 104, 582-7 (2007) (Pubitemid 46123068)
86. Hamazaki, H., S. Ujino, N. Miyano-Kurosaki, K. Shimotohno & H. Takaku: Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons. Biochem Biophys Res Commun, 343, 988-94 (2006)
87. Zhu, H., H. Dong, E. Eksioglu, A. Hemming, M. Cao, J. M. Crawford, D. R. Nelson & C. Liu: Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology, 133, 1649-59 (2007) (Pubitemid 350029762)
88. Maire, M., R. Parent, A. L. Morand, C. Alotte, C. Trepo, D. Durantel & M. A. Petit: Characterization of the double-stranded RNA responses in human liver progenitor cells. Biochem Biophys Res Commun, 368, 556-62 (2008)
89. Vilasco, M., E. Larrea, D. Vitour, S. Dabo, A. Breiman, B. Regnault, J. I. Riezu, P. Eid, J. Prieto & E. F. Meurs: The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers. Hepatology, 44, 1635-47 (2006) (Pubitemid 44970358)
90. Iwasaki, A. & R. Medzhitov: Toll-like receptor control of the adaptive immune responses. Nat Immunol, 5, 987-95 (2004) (Pubitemid 41057715)
91. Kaukinen, P., M. Sillanpaa, S. Kotenko, R. Lin, J. Hiscott, K. Melen & I. Julkunen: Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J, 3, 66 (2006)
92. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira & C. Reis e Sousa: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303, 1529-31 (2004) (Pubitemid 38314425)
93. Sen, G. C. & S. N. Sarkar: Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev, 16, 1-14 (2005) (Pubitemid 40279114)
94. Meurs, E. F. & A. Breiman: The interferon inducing pathways and the hepatitis C virus. World J Gastroenterol, 13, 2446-54 (2007) (Pubitemid 46929500)
95. Choe, J., M. S. Kelker & I. A. Wilson: Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science, 309, 581-5 (2005) (Pubitemid 41033635)
96. Kawai, T. & S. Akira: Innate immune recognition of viral infection. Nat Immunol, 7, 131-7 (2006) (Pubitemid 43135878)
97. Hiscott, J., R. Lin, P. Nakhaei & S. Paz: MasterCARD: a priceless link to innate immunity. Trends Mol Med, 12, 53-6 (2006) (Pubitemid 43202122)
98. Seth, R. B., L. Sun, C. K. Ea & Z. J. Chen: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NFkappaB and IRF 3. Cell, 122, 669-82 (2005) (Pubitemid 41242633)
99. Hiscott, J., J. Lacoste & R. Lin: Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease. Biochem Pharmacol, 72, 1477-84 (2006) (Pubitemid 44666740)
100. Marie, I., J. E. Durbin & D. E. Levy: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J, 17, 6660-9 (1998) (Pubitemid 28521799)
101. Sato, M., N. Tanaka, N. Hata, E. Oda & T. Taniguchi: Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett, 425, 112-6 (1998) (Pubitemid 28149751)
102. Thompson, A. J. & S. A. Locarnini: Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol, 85, 435-45 (2007) (Pubitemid 47367510)
103. Peters, R. T., S. M. Liao & T. Maniatis: IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell, 5, 513-22 (2000)
104. Wagoner, J., M. Austin, J. Green, T. Imaizumi, A. Casola, A. Brasier, K. S. Khabar, T. Wakita, M. Gale, Jr. & S. J. Polyak: Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol, 81, 309-18 (2007) (Pubitemid 44975171)
105. Bowie, A. G. & L. Unterholzner: Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol, 8, 911-22 (2008)
106. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager & J. Tschopp: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437, 1167-72 (2005) (Pubitemid 41509355)
107. Loo, Y. M., D. M. Owen, K. Li, A. K. Erickson, C. L. Johnson, P. M. Fish, D. S. Carney, T. Wang, H. Ishida, M. Yoneyama, T. Fujita, T. Saito, W. M. Lee, C. H. Hagedorn, D. T. Lau, S. A. Weinman, S. M. Lemon & M. Gale, Jr.: Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A, 103, 6001-6 (2006)
108. Wornle, M., H. Schmid, B. Banas, M. Merkle, A. Henger, M. Roeder, S. Blattner, E. Bock, M. Kretzler, H. J. Grone & D. Schlondorff: Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol, 168, 370-85 (2006) (Pubitemid 43271137)
109. Duesberg, U., A. von dem Bussche, C. Kirschning, K. Miyake, T. Sauerbruch & U. Spengler: Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)-core protein is mediated by toll like receptors (TLRs) 2 and 4. Immunol Lett, 84, 89-95 (2002) (Pubitemid 35248001)
110. Xia, C., M. Lu, Z. Zhang, Z. Meng & C. Shi: TLRs antiviral effect on hepatitis B virus in HepG2 cells. J Appl Microbiol, 105, 1720-7 (2008)
111. Wang, C., J. Pflugheber, R. Sumpter, Jr., D. L. Sodora, D. Hui, G. C. Sen & M. Gale, Jr.: Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol, 77, 3898-912 (2003) (Pubitemid 36350931)
112. Sillanpaa, M., P. Kaukinen, K. Melen & I. Julkunen: Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression. J Gen Virol, 89, 432-43 (2008) (Pubitemid 351622440)
113. Martini, F., A. Sacchi, E. Lalle, C. Castilletti, G. D'Offizi, I. Abbate & M. R. Capobianchi: GB virus type Cdriven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation. Gastroenterology, 134, 1631-3; author reply 1633 (2008) (Pubitemid 351615405)
114. He, Q., C. S. Graham, E. Durante Mangoni & M. J. Koziel: Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. Liver Int, 26, 1100-10 (2006) (Pubitemid 44541751)
115. Askar, E., R. Bregadze, J. Mertens, S. Schweyer, A. Rosenberger, G. Ramadori & S. Mihm: TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J Med Virol, 81, 1204-11 (2009)
116. Atencia, R., F. J. Bustamante, A. Valdivieso, A. Arrieta, M. Rinon, A. Prada & N. Maruri: Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infect Dis, 7, 136 (2007)
117. Mozer-Lisewska, I., W. Sluzewski, M. Kaczmarek, R. Jenek, M. Szczepanski, M. Figlerowicz, A. Kowala-Piaskowska & J. Zeromski: Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol, 62, 407-12 (2005) (Pubitemid 41565394)
118. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner & S. Bauer: Species-specific recognition of single-stranded RNA via tolllike receptor 7 and 8. Science, 303, 1526-9 (2004) (Pubitemid 38314424)
119. Gorden, K. B., K. S. Gorski, S. J. Gibson, R. M. Kedl, W. C. Kieper, X. Qiu, M. A. Tomai, S. S. Alkan & J. P. Vasilakos: Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol, 174, 1259-68 (2005)
120. Nishimura, M. & S. Naito: Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull, 28, 886-92 (2005) (Pubitemid 40740661)
121. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom & C. Reis e Sousa: Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature, 433, 887-92 (2005) (Pubitemid 40314900)
122. Matsumoto, M., K. Funami, M. Tanabe, H. Oshiumi, M. Shingai, Y. Seto, A. Yamamoto & T. Seya: Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol, 171, 3154-62 (2003) (Pubitemid 37093540)
123. Wertheimer, A. M., S. J. Polyak, R. Leistikow & H. R. Rosen: Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells. Hepatology, 45, 1422-32 (2007) (Pubitemid 46918326)
124. Matijevic, T., M. Marjanovic & J. Pavelic: Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol, 70, 18-24 (2009)
125. Barton, G. M. & R. Medzhitov: Toll signaling: RIPping off the TNF pathway. Nat Immunol, 5, 472-4 (2004) (Pubitemid 38660456)
126. Au, W. C., P. A. Moore, D. W. LaFleur, B. Tombal & P. M. Pitha: Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem, 273, 29210-7 (1998) (Pubitemid 28507622)
127. Lin, R., C. Heylbroeck, P. Genin, P. M. Pitha & J. Hiscott: Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol, 19, 959-66 (1999) (Pubitemid 29046840)
128. Lin, R., C. Heylbroeck, P. M. Pitha & J. Hiscott: Virusdependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol, 18, 2986-96 (1998) (Pubitemid 28183468)
129. Lin, R., Y. Mamane & J. Hiscott: Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol, 19, 2465-74 (1999) (Pubitemid 29144490)
130. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka & T. Taniguchi: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity, 13, 539-48 (2000)
131. Sato, M., N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi & N. Tanaka: Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett, 441, 106-10 (1998) (Pubitemid 29012382)
132. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida & T. Fujita: Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. Embo J, 17, 1087-95 (1998) (Pubitemid 28077662)
133. Breiman, A., D. Vitour, M. Vilasco, C. Ottone, S. Molina, L. Pichard, C. Fournier, D. Delgrange, P. Charneau, G. Duverlie, C. Wychowski, P. Maurel & E. F. Meurs: A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. J Gen Virol, 87, 3587-98 (2006) (Pubitemid 44816992)
134. Breiman, A., N. Grandvaux, R. Lin, C. Ottone, S. Akira, M. Yoneyama, T. Fujita, J. Hiscott & E. F. Meurs: Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol, 79, 3969-78 (2005) (Pubitemid 40388337)
135. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira & T. Fujita: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol, 5, 730-7 (2004) (Pubitemid 39023305)
136. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda & S. Akira: The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med, 199, 1641-50 (2004) (Pubitemid 38821997)
137. Abe, T., Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, N. Hayashi, S. Akira & Y. Matsuura: Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol, 81, 8953-66 (2007) (Pubitemid 47311439)
138. Yoneyama, M. & T. Fujita: Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem, 282, 15315-8 (2007) (Pubitemid 47093255)
139. Li, K., Z. Chen, N. Kato, M. Gale, Jr. & S. M. Lemon: Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem, 280, 16739-47 (2005) (Pubitemid 41389131)
140. Dansako, H., M. Ikeda & N. Kato: Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes. FEBS J, 274, 4161-76 (2007) (Pubitemid 47228632)
141. Rothenfusser, S., N. Goutagny, G. DiPerna, M. Gong, B. G. Monks, A. Schoenemeyer, M. Yamamoto, S. Akira & K. A. Fitzgerald: The RNA helicase Lgp2 inhibits TLRindependent sensing of viral replication by retinoic acidinducible gene-I. J Immunol, 175, 5260-8 (2005) (Pubitemid 41456411)
142. Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y. M. Loo, M. Gale, Jr., S. Akira, S. Yonehara, A. Kato & T. Fujita: Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol, 175, 2851-8 (2005) (Pubitemid 41170502)
143. Melen, K., R. Fagerlund, M. Nyqvist, P. Keskinen & I. Julkunen: Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol, 73, 536-47 (2004) (Pubitemid 38857203)
144. Barba, G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura & C. Brechot: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A, 94, 1200-5 (1997) (Pubitemid 27087828)
145. Schwer, B., S. Ren, T. Pietschmann, J. Kartenbeck, K. Kaehlcke, R. Bartenschlager, T. S. Yen & M. Ott: Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol, 78, 7958-68 (2004) (Pubitemid 38944281)
146. Li, X. D., L. Sun, R. B. Seth, G. Pineda & Z. J. Chen: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A, 102, 17717-22 (2005) (Pubitemid 41803563)
147. Johnson, C. L., D. M. Owen & M. Gale, Jr.: Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem, 282, 10792-803 (2007) (Pubitemid 47093463)
148. Nomura-Takigawa, Y., M. Nagano-Fujii, L. Deng, S. Kitazawa, S. Ishido, K. Sada & H. Hotta: Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol, 87, 1935-45 (2006) (Pubitemid 43985876)
149. Cebulla, C. M., D. M. Miller & D. D. Sedmak: Viral inhibition of interferon signal transduction. Intervirology, 42, 325-30 (1999) (Pubitemid 30122067)
150. Chang, Y. E. & L. A. Laimins: Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol, 74, 4174-82 (2000) (Pubitemid 30214423)
151. Tan, S. L. & M. G. Katze: How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology, 284, 1-12 (2001) (Pubitemid 32476690)
152. Pflugheber, J., B. Fredericksen, R. Sumpter, Jr., C. Wang, F. Ware, D. L. Sodora & M. Gale, Jr.: Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A, 99, 4650-5 (2002) (Pubitemid 34286039)
153. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber & M. M. Lai: Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science, 285, 107-10 (1999) (Pubitemid 29307576)
154. Gale, M., Jr., B. Kwieciszewski, M. Dossett, H. Nakao & M. G. Katze: Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol, 73, 6506-16 (1999) (Pubitemid 29327831)
155. Clemens, M. J., J. W. Hershey, A. C. Hovanessian, B. C. Jacobs, M. G. Katze, R. J. Kaufman, P. Lengyel, C. E. Samuel, G. C. Sen & B. R. Williams: PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J Interferon Res, 13, 241 (1993) (Pubitemid 23182684)
156. Meurs, E., K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr, B. R. Williams & A. G. Hovanessian: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell, 62, 379-90 (1990)
157. Clemens, M. J. & A. Elia: The double-stranded RNAdependent protein kinase PKR: structure and function. J Interferon Cytokine Res, 17, 503-24 (1997) (Pubitemid 27475916)
158. Samuel, C. E., K. L. Kuhen, C. X. George, L. G. Ortega, R. Rende-Fournier & H. Tanaka: The PKR protein kinase-an interferon-inducible regulator of cell growth and differentiation. Int J Hematol, 65, 227-37 (1997) (Pubitemid 27154170)
159. Guo, J. T., Q. Zhu & C. Seeger: Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. J Virol, 77, 10769-79 (2003) (Pubitemid 37204270)
160. Weber, F.: Interaction of hepatitis C virus with the type I interferon system. World J Gastroenterol, 13, 4818-23 (2007) (Pubitemid 47496746)
161. Rodriguez-Inigo, E., J. Bartolome, S. de Lucas, F. Manzarbeitia, M. Pardo, C. Arocena, J. Gosalvez, H. Oliva & V. Carreno: Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol, 154, 1877-81 (1999) (Pubitemid 29262871)
162. Zhou, S., N. A. Terrault, L. Ferrell, J. A. Hahn, J. Y. Lau, P. Simmonds, J. P. Roberts, J. R. Lake, N. L. Ascher & T. L. Wright: Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology, 24, 1041-6 (1996) (Pubitemid 26365900)
163. Puoti, C., T. Stati & A. Magrini: Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. Liver, 19, 104-9 (1999) (Pubitemid 29139762)
164. Romeo, R., M. Colombo, M. Rumi, R. Soffredini, E. Del Ninno, M. F. Donato, A. Russo & P. Simmonds: Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat, 3, 183-90 (1996) (Pubitemid 126733933)
165. Fukushima, S., S. Hirata, Y. Motomura, D. Fukuma, Y. Matsunaga, Y. Ikuta, T. Ikeda, T. Kageshita, H. Ihn, Y. Nishimura & S. Senju: Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells. J Immunother, 32, 219-31 (2009)
166. Natoli, G. & L. M. Austenaa: A birthday gift for TRADD. Nat Immunol, 9, 1015-6 (2008)
167. Ray, R. B., K. Meyer & R. Ray: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology, 226, 176-82 (1996) (Pubitemid 27025796)
168. Zhu, N., A. Khoshnan, R. Schneider, M. Matsumoto, G. Dennert, C. Ware & M. M. Lai: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol, 72, 3691-7 (1998) (Pubitemid 28188666)
169. Hosui, A., K. Ohkawa, H. Ishida, A. Sato, F. Nakanishi, K. Ueda, T. Takehara, A. Kasahara, Y. Sasaki, M. Hori & N. Hayashi: Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli. J Biol Chem, 278, 28562-71 (2003) (Pubitemid 36935761)
170. Miller, K., S. McArdle, M. J. Gale, Jr., D. A. Geller, B. Tenoever, J. Hiscott, D. R. Gretch & S. J. Polyak: Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res, 24, 391-402 (2004) (Pubitemid 38998788)
171. Takahashi, H. & M. Zeniya: Do DCs influence the antiviral effect of interferon/ribavirin by changing their profile during the therapy? J Gastroenterol, 41, 816-7 (2006) (Pubitemid 44446141)
172. Franck, N., J. Le Seyec, C. Guguen-Guillouzo & L. Erdtmann: Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol, 79, 2700-8 (2005) (Pubitemid 40270548)
173. Prikhod'ko, E. A., G. G. Prikhod'ko, R. M. Siegel, P. Thompson, M. E. Major & J. I. Cohen: The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities. Virology, 329, 53-67 (2004) (Pubitemid 39346028)